Faron to Hold Conference Call to Discuss New Positive Clinic

TURKU, Finland and BOSTON, July 19, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, will hold a conference call today to discuss new positive clinical data from the Company's ongoing Phase I/II BEXMAB study. Conference Call and Webcast Wednesday, July 19, 2023, at 8:30 am ET. The live call may be accessed by dialing (877) 407-3982 for callers in the US and (201)

Related Keywords

Boston , Massachusetts , United States , Finland , Jukka , Lapland , Christopher Golden , Juha Karttunen , Sandy Jamieson , Jenniferc Smith Parker , Jo Turner , Faron Pharmaceuticals Ltd , Faron Pharmaceuticals , Head Of Communications , Peel Hunt , Cairn Financial Advisers , First North , Investor Relations Calendar , Certified Adviser , Nasdaq First , Biopharmaceutical Company , The Company , Company , Immune System , Mmunotherapies ,